Nearly 10,000km (4,000 miles) away in Lebanon, Beirut, suspected fake Ozempic vials accounted for almost a dozen instances of dangerously low blood sugar in patients, including one case that required hospitalisation in November
Dosing The dose of this medicine will be different for different patients
Keeping up to date is important
Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist, the next breakthrough
Incremental Increases To avoid diarrhea on Tirzepatide, the dosage is gradually raised over time, adhering to a predetermined titration schedule which may include the incremental elevation of doses at specific intervals (such as weekly or biweekly) depending on how well the patient responds and can tolerate it